Einstein (Sao Paulo, Brazil) · 2026
Quantification of Y RNAs in peripheral blood mononuclear cells from patients with ankylosing spondylitis and healthy controls.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Castellani Guilherme, Braga Matheus, Yamanaka Aléia Harumi Uchibaba, Bemvides Giovana Paola Zaccarias, Schavaren Julyane, Pinto Larissa Danielle Bahls, Lima Neto Quirino Alves de
Аннотация
OBJECTIVE: To investigate the expression of Y1, Y3, Y4, and Y5 in peripheral blood mononuclear cells from patients with ankylosing spondylitis and healthy controls.
METHODS: This case-control study included 10 patients with ankylosing spondylitis and 18 healthy controls from northern and northwestern Paraná, Brazil. The diagnosis of ankylosing spondylitis was confirmed by a rheumatologist according to the 2009 and 2011 ASAS criteria. Total RNA was extracted from peripheral blood using TRIzol reagent, treated with DNase I, and reverse-transcribed into cDNA. Y RNA expression was quantified by qPCR using SYBR™ Green, and the data were analyzed using Thermo Fisher Cloud.
RESULTS: Overall Y RNA expression did not differ significantly between patients and controls; however, lower ΔCt values, indicating higher Y1 and Y5 expression, were significantly associated with higher Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores. Pairwise comparisons showed that Y3 and Y4 were expressed at lower levels than Y1 and that Y4 expression was lower than Y3 and Y5 expression; no significant differences were observed between Y1 and Y5 or between Y3 and Y5 in either patients or controls.
CONCLUSION: These findings suggest that Y1 and Y5 expression is associated with disease activity, although no statistically significant differences in overall Y RNA expression were observed between patients and controls.
METHODS: This case-control study included 10 patients with ankylosing spondylitis and 18 healthy controls from northern and northwestern Paraná, Brazil. The diagnosis of ankylosing spondylitis was confirmed by a rheumatologist according to the 2009 and 2011 ASAS criteria. Total RNA was extracted from peripheral blood using TRIzol reagent, treated with DNase I, and reverse-transcribed into cDNA. Y RNA expression was quantified by qPCR using SYBR™ Green, and the data were analyzed using Thermo Fisher Cloud.
RESULTS: Overall Y RNA expression did not differ significantly between patients and controls; however, lower ΔCt values, indicating higher Y1 and Y5 expression, were significantly associated with higher Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores. Pairwise comparisons showed that Y3 and Y4 were expressed at lower levels than Y1 and that Y4 expression was lower than Y3 and Y5 expression; no significant differences were observed between Y1 and Y5 or between Y3 and Y5 in either patients or controls.
CONCLUSION: These findings suggest that Y1 and Y5 expression is associated with disease activity, although no statistically significant differences in overall Y RNA expression were observed between patients and controls.